Genetic interaction between Tmprss2-ERG gene fusion and Nkx3.1-loss does not enhance prostate tumorigenesis in mouse models

PloS One
Douglas E LinnZhe Li

Abstract

Gene fusions involving ETS family transcription factors (mainly TMPRSS2-ERG and TMPRSS2-ETV1 fusions) have been found in ~50% of human prostate cancer cases. Although expression of TMPRSS2-ERG or TMPRSS2-ETV1 fusion alone is insufficient to initiate prostate tumorigenesis, they appear to sensitize prostate epithelial cells for cooperation with additional oncogenic mutations to drive frank prostate adenocarcinoma. To search for such ETS-cooperating oncogenic events, we focused on a well-studied prostate tumor suppressor NKX3.1, as loss of NKX3.1 is another common genetic alteration in human prostate cancer. Previous studies have shown that deletions at 8p21 (harboring NKX3.1) and 21q22 (resulting in TMPRSS2-ERG fusion) were both present in a subtype of prostate cancer cases, and that ERG can lead to epigenetic silencing of NKX3.1 in prostate cancer cells, whereas NKX3.1 can in turn negatively regulate TMPRSS2-ERG fusion expression via suppression of the TMPRSS2 promoter activity. We recently generated knockin mouse models for TMPRSS2-ERG and TMPRSS2-ETV1 fusions, utilizing the endogenous Tmprss2 promoter. We crossed these knockin models to an Nkx3.1 knockout mouse model. In Tmprss2-ERG;Nkx3.1+/- (or -/-) male mice, although we o...Continue Reading

References

Apr 24, 1999·Genes & Development·R Bhatia-GaurM M Shen
Sep 26, 2000·Developmental Dynamics : an Official Publication of the American Association of Anatomists·M TanakaS Izumo
Feb 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Minjung J KimCory Abate-Shen
Aug 7, 2002·The American Journal of Pathology·Jae-Hak ParkRobert D Cardiff
Oct 29, 2005·Science·Scott A TomlinsArul M Chinnaiyan
Sep 19, 2007·Cancer Research·Jacques LapointeJonathan R Pollack
Feb 5, 2008·Proceedings of the National Academy of Sciences of the United States of America·Olga KlezovitchValeri Vasioukhin
Feb 20, 2008·Neoplasia : an International Journal for Oncology Research·Scott A TomlinsArul M Chinnaiyan
May 29, 2008·Journal of the National Cancer Institute·Sunita R SetlurMark A Rubin
Jun 19, 2008·Differentiation; Research in Biological Diversity·Cory Abate-ShenEdward Gelmann
Jun 20, 2008·Nature Reviews. Cancer·Chandan Kumar-SinhaArul M Chinnaiyan
Jan 22, 2009·Genes, Chromosomes & Cancer·Francesca DemichelisMark A Rubin
Jan 30, 2009·Science Signaling·Caterina NardellaPier Paolo Pandolfi
Feb 13, 2009·Nature·Brett S CarverPier Paolo Pandolfi
Apr 28, 2009·Nature Genetics·Jennifer C KingCharles L Sawyers
Jul 14, 2009·Proceedings of the National Academy of Sciences of the United States of America·Yang ZongOwen N Witte
Jun 29, 2010·Cancer Cell·Barry S TaylorWilliam L Gerald
Sep 17, 2010·Genes & Development·Michael M Shen, Cory Abate-Shen
Jun 28, 2012·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Andreas PetterssonLorelei A Mucci
Apr 4, 2013·Science Signaling·Jianjiong GaoNikolaus Schultz

❮ Previous
Next ❯

Citations

Apr 18, 2018·Cold Spring Harbor Perspectives in Medicine·Juan M Arriaga, Cory Abate-Shen
Sep 6, 2018·Genes & Development·Guocan WangRonald A DePinho
Oct 13, 2016·Mitochondrial DNA. Part A. DNA Mapping, Sequencing, and Analysis·H Abdul JaffaraliKaleem Ml Arshan

❮ Previous
Next ❯

Methods Mentioned

BETA
transgenic
PCR
flow cytometry
FACS

Software Mentioned

Primer3
GraphPad Prism

Related Concepts

Related Feeds

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.